Related Experiment Video
Updated: Jul 7, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Role of homologous recombination in trabectedin-induced DNA damage
M Tavecchio1, M Simone, E Erba
1Department of Oncology, Istituto di Ricerche Farmacologiche "Mario Negri", Via La Masa 19, 20156 Milan, Italy.
Abstract:
Trabectedin (ET-743, Yondelis) is a natural marine compound with antitumour activity currently undergoing phase II/III clinical trials. The mechanism of the drug's action is still to be defined, even though it has been clearly demonstrated the key role of Nucleotide Excision Repair (NER). To get further insights into the drug's mode of action, we studied the involvement of the DNA-double strand break repair (DNA-DSB) pathways: homologous and non-homologous recombination, both in budding yeasts and in mammalian cells and the possible cross-talk between NER and these repair pathways. Budding yeasts and mammalian cells deficient in the non-homologous end-joining pathway were moderately sensitive to trabectedin, while systems deficient in the homologous recombination pathway were extremely sensitive to the drug, with a 100-fold decrease in the IC50, suggesting that trabectedin-induced lesions are repaired by this pathway. The induction of Rad51 foci and the appearance of gamma-H2AX were chosen as putative markers for DNA-DSBs and were studied at different time points after trabectedin treatment in NER proficient and deficient systems. Both were clearly detected only in the presence of an active NER, suggesting that the DSBs are not directly caused by the drug, but are formed during the processing/repair of the drug- induced lesions.
Insights
Trabectedin
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Trabectedin is a marine-derived antitumour compound.
- Its precise mechanism of action is under investigation, with Nucleotide Excision Repair (NER) playing a known role.
- Understanding DNA repair pathway involvement is crucial for defining its therapeutic potential.
Purpose of the Study:
- To investigate the role of DNA double-strand break (DSB) repair pathways in trabectedin's mechanism of action.
- To explore the cross-talk between NER and homologous recombination (HR) and non-homologous end-joining (NHEJ) pathways.
- To identify markers indicative of trabectedin-induced DNA damage.
Main Methods:
- Assessing trabectedin sensitivity in budding yeast and mammalian cells deficient in HR and NHEJ.
- Monitoring the induction of Rad51 foci and gamma-H2AX as markers for DNA-DSBs.
- Comparing DNA-DSB marker induction in NER-proficient versus NER-deficient cells.
Main Results:
- Cells deficient in homologous recombination (HR) exhibited extreme sensitivity to trabectedin (100-fold decrease in IC50).
- Cells deficient in non-homologous end-joining (NHEJ) showed moderate sensitivity.
- Rad51 foci and gamma-H2AX induction, indicative of DNA-DSBs, were observed only in NER-proficient cells, suggesting DSBs arise during repair of trabectedin lesions.
Conclusions:
- Homologous recombination is the primary pathway for repairing trabectedin-induced DNA lesions.
- DNA double-strand breaks are a consequence of the repair process mediated by Nucleotide Excision Repair, not a direct effect of trabectedin.
- This clarifies trabectedin's mechanism, highlighting the interplay between DNA repair pathways.
Related Concept Videos
Homologous Recombination
Homologous Recombination
Nucleotide Excision Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Fixing Double-strand Breaks

